Boston Scientific (BSX) stock
Last close $42.99 on 2026-11-19 (-1.49%) · Sector: Healthcare
Boston Scientific makes medical devices used in procedures that doctors perform inside the body, such as heart and vascular treatments. It earns money mainly by selling these devices to hospitals and clinics, and its revenue comes from a large number of procedure-related products.
Sales are still growing, with revenue up 8.9% over the past year and quarterly revenue near $5 billion. However, the stock has fallen 55.5% over the past year while the S&P 500 rose 9.7%, so it has trailed the broader market by a wide margin. The share price moved up 9.0% after one earnings release but fell after two others, including a 17.6% drop in February. The CEO recently bought $9.0 million of company stock, while a Congress member made several small sales.
Key numbers
- Market cap: $62.4B
- Revenue (last 12 months): $21.07B
- Revenue growth: +8.9%
- Gross margin: 69.1%
- Operating margin: 18.7%
- P/E: 18.2
- P/S: 3.0
- Debt to equity: 0.19
- Current ratio: 1.36
Quality score
Overall 50/100 · growth 37 · profitability 42 · financial health 63 · value 57
Performance and risk
1-year return -55.5% vs S&P 500 +9.7% · volatility 40.1% (S&P 500 13.8%) · largest drop -59.1% · beta 0.27
Stock move the day after earnings
- 2026-02-04: -17.6%
- 2026-04-22: +9.0%
- 2026-07-29: -0.0%
- 2026-10-28: -5.8%
Congress trades (90 days)
0 buys, 4 sells
Insider trades (12 months)
Bought $10.1M · sold $16.8M
BSX stock research · BSX options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.